Go to deals
TMT

Bigtincan (ASX:BTH) recently raised funds via a single-tranche placement, followed by an SPP

Bigtincan (ASX:BTH) has raised funds to support future inorganic growth initiatives.

Bigtincan is a software company that has developed an AI-powered sales enablement automation platform aimed at achieving improved success of sales and customer satisfaction. The mobile platform solution features the industry’s premier user experience that empowers sales representatives to engage more effectively with customers and prospects and encourages team-wide adoption.

Oaklins’ team in Australia acted as joint lead manager to Bigtincan Holdings Limited on its recent capital raising. This is the fourth capital raising the team has conducted for BTH and we look forward to continuing to support them as they become a global leader in the sales enablement industry.

Talk to the deal team

Justin Lewis

Managing Director
Melbourne, Australia
Oaklins Henslow

Stephen Macaw

Director
Melbourne, Australia
Oaklins Henslow

Related deals

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

Learn more
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more